The University of Chicago Header Logo

Connection

Walter M. Stadler to Mifepristone

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Mifepristone.
Walter M. Stadler
Connection Strength
0.051
Mifepristone
  1. Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1549-1559.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.